Drugs / MSI-1436C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02524951 | Apr 2016 → Jul 2017 | breast cancer | Northwell Health | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSI-1436C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02524951 ↗ |
| Route | Intravenous | “single intravenous infusion” NCT02524951 ↗ |